A Study of a Novel Scheimpflug Device in Diagnosing Keratoconus
NCT ID: NCT06119321
Last Updated: 2024-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2023-05-04
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evolution of a Novel Optical Coherence Tomography Based Index in Diagnosing Keratoconus
NCT06152484
Evaluation of Morphology Abnormal Cornea Stability With Corneal Biomechanical
NCT05748002
A Novel Method to Assess the Cornea Biomechanical Properties With Schiotz Tonometer
NCT02475343
Assessment of Corneal Stiffness in Keratoconus After Crosslinking by Corvis ST and OCT.
NCT05161052
Multi-center Clinical Trial on Corneal Morphology Analysis in Chinese Population
NCT03010748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal control group
Pentacam, Corvis ST and Scansys
morphological and biomechanical parameters of corneal were obtain by Scansys, Pentacam and Corvis ST
Subclinical keratoconus
Pentacam, Corvis ST and Scansys
morphological and biomechanical parameters of corneal were obtain by Scansys, Pentacam and Corvis ST
Keratoconus
Pentacam, Corvis ST and Scansys
morphological and biomechanical parameters of corneal were obtain by Scansys, Pentacam and Corvis ST
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pentacam, Corvis ST and Scansys
morphological and biomechanical parameters of corneal were obtain by Scansys, Pentacam and Corvis ST
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No other eye diseases except myopia and astigmatism;
* The cornea was transparent, and there was no cloud or pannus;
Exclusion Criteria
* Ocular trauma;
* Previous ocular surgery;
* Patients were required to stop wearing soft contact lenses for at least 2 weeks and rigid contact lenses for at least 4 weeks before examination;
* Pregnant and lactating women;
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tianjin Eye Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Wang, Prof
Role: STUDY_CHAIR
Tianjin Eye Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tiajin Eye Hospital
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY2023026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.